Eliminate Malaria

We are committed to making a major contribution in efforts to eliminate malaria as a public health threat, particularly in our region.

One of the leading causes of mortality and morbidity globally, malaria was responsible for around 435,000 deaths and 216 million clinical cases in 2017. An estimated 3.2 billion people are at risk of the disease, with young children and pregnant women most affected.

A two-way pipeline will be created where our research discoveries can be tested in the field, and field programs inform discovery research through our long-standing connections with vulnerable target populations, especially in Papua New Guinea and Myanmar.

Through this program, Burnet will contribute to:

  • reaching the WHO elimination targets of a 90 percent reduction in malaria incidence and mortality through an active program of basic, discovery and translational research and in-field education, prevention and treatment programs.

  • supporting country programs in our region that assist WHO in reaching targets of elimination in at least 35 countries by 2030.


Contact Details

Professor James Beeson

Deputy Director (People); Head of Malaria Immunity and Vaccines Laboratory; Adjunct Professor Monash University






Latest News

    11 September, 2019

    New platform for malaria vaccine research

    New research led by Burnet has demonstrated the effective use of novel virus-like particles for malaria vaccines.

    29 August, 2019

    NHMRC Investigator Grants

    Burnet Institute’s Professor James Beeson, and drug and alcohol researcher Dr Amanda Roxburgh have been awarded NHMRC Investigator Grants.

Upcoming Events

  • There are no upcoming events at present.